Umbilical Cord Blood Transplantation Outcomes in Acute Myelogenous Leukemia/Myelodysplastic Syndromes Patients ≥70 Years Old

The maximum age of patients receiving allogeneic hematopoietic stem cell transplantation (alloHCT) has been moving up over time. However, the availability of a suitable HLA-matched sibling donor may limit access of this patient population to alloHCT. We retrospectively investigated the outcomes of u...

Cijeli opis

Spremljeno u:
Bibliografski detalji
Izdano u:Biol Blood Marrow Transplant
Glavni autori: Sandhu, Karamjeet S, Brunstein, Claudio, DeFor, Todd, Bejanyan, Nelli, Arora, Mukta, Warlick, Erica, Weisdorf, Daniel, Ustun, Celalettin
Format: Artigo
Jezik:Inglês
Izdano: 2015
Teme:
Article
Online pristup:https://ncbi.nlm.nih.gov/pmc/articles/PMC4768714/
https://ncbi.nlm.nih.gov/pubmed/26415559
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.bbmt.2015.09.020
Oznake: Dodaj oznaku
Bez oznaka, Budi prvi tko označuje ovaj zapis!

Similar Items